Hula Therapeutics is a pediatric oncology company.
Hula Therapeutics has raised $250K in total funding. The most recent round was Pre-Seed. The last funding was announced in July 2024.
Hula Therapeutics's investors include Hatch Biofund Management.
Hula Therapeutics is headquartered in Philadelphia, United States.
Hula Therapeutics is a pediatric oncology company.
Hula Therapeutics is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hula Therapeutics — Funding & Investors." VCBacked, July 19, 2024, https://www.vcbacked.co/company/hula-therapeutics. Accessed August 16, 2026.
VCBacked. (2024). Hula Therapeutics — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/hula-therapeutics
{{cite web |title=Hula Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/hula-therapeutics |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated